Advanced search
Publication Cover
Autoimmunity Volume 48, 2015 - Issue 4
Submit an article Journal homepage
686
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Interleukin-17 is a critical target for the treatment of ankylosing enthesitis and psoriasis-like dermatitis in mice

Shin EbiharaDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan and Correspondence[email protected]
,
Fumiko DateDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan and
,
Yupeng DongDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan and
&
Masao OnoDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan and ;Mito Medical Center, National Hospital Organization, Higashi-ibaraki, Japan
Pages 259-266 | Received 18 Jun 2014, Accepted 05 Oct 2014, Published online: 29 Oct 2014

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Fabiola Atzeni, Antonio Carriero, Laura Boccassini & Salvatore D’Angelo. (2021) Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis. ImmunoTargets and Therapy 10, pages 141-153.
Read now
Stephanie R Harrison & Helena Marzo-Ortega. (2021) Ixekizumab: an IL-17A inhibitor for the treatment of axial Spondylarthritis. Expert Review of Clinical Immunology 17:10, pages 1059-1071.
Read now
Duo Li, Bin Guo, Haijing Wu, Lina Tan, Christopher Chang & Qianjin Lu. (2015) Interleukin-17 in systemic lupus erythematosus: A comprehensive review. Autoimmunity 48:6, pages 353-361.
Read now

Articles from other publishers (29)

Anastasiia Kotliarova, Anna S. Davydova, Veronika E. Goncharova, Yuliya D. Kurochkina, Viktor S. Ovchinnikov, Mariya A. Vorobyeva & Maksim A. Korolev. (2022) Anti-IL-17 nucleic acid aptamer alleviates motor impairment in mouse spondyloarthritis model. Anti-IL-17 nucleic acid aptamer alleviates motor impairment in mouse spondyloarthritis model.
Ihsan Hammoura, Renee H. Fiechter, Shaughn H. Bryant, Susan Westmoreland, Gillian Kingsbury, Wendy Waegell, Sander W. Tas, Dominique L. Baeten, Marleen G. H. van de Sande, Melissa N. van Tok & Leonie M. van Duivenvoorde. (2022) Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis. International Journal of Molecular Sciences 23:2, pages 859.
Crossref
Maryam Akhtari. 2022. Ankylosing Spondylitis - Axial Spondyloarthritis. Ankylosing Spondylitis - Axial Spondyloarthritis 49 82 .
Runsheng Wang & Walter P. Maksymowych. (2021) Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis. Frontiers in Immunology 12.
Crossref
Patricia Harkins, Eoghan Burke, Catherine Swales & Alan Silman. (2021) ‘All disease begins in the gut’—the role of the intestinal microbiome in ankylosing spondylitis. Rheumatology Advances in Practice 5:3.
Crossref
Yu-Wen Huang, Jing-Wun Lu & Tai-Li Chen. (2021) Volumetric Bone Mineral Density Measured by HR-pQCT in Patients with Psoriasis or Psoriatic Arthritis: A Systematic Review and Meta-Analysis with Trial Sequential Analysis. Healthcare 9:8, pages 1056.
Crossref
Joan Defrêne, Sofiane Berrazouane, Nayeli Esparza, Nathalie Pagé, Marie-France Côté, Stéphane Gobeil, Fawzi Aoudjit & Philippe A. Tessier. (2021) Deletion of S100a8 and S100a9 Enhances Skin Hyperplasia and Promotes the Th17 Response in Imiquimod-Induced Psoriasis . The Journal of Immunology 206:3, pages 505-514.
Crossref
Suling Liu, Yang Cui & Xiao Zhang. (2020) Molecular mechanisms and clinical studies of iguratimod for the treatment of ankylosing spondylitis. Clinical Rheumatology 40:1, pages 25-32.
Crossref
Aniruddha Voruganti & Paul Bowness. (2020) New developments in our understanding of ankylosing spondylitis pathogenesis. Immunology 161:2, pages 94-102.
Crossref
Yong-Zhi Ji & Shi-Rui Liu. (2019) Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms. Bioscience Reports 39:12.
Crossref
Dennis G McGonagle, Iain B McInnes, Bruce W Kirkham, Jonathan Sherlock & Robert Moots. (2019) The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies. Annals of the Rheumatic Diseases 78:9, pages 1167-1178.
Crossref
Xu Zhang, Yaping Yuan, Zhipeng Pan, Yubo Ma, Meng Wu, Jiajia Yang, Renfang Han, Mengya Chen, Xingxing Hu, Rui Liu, Napoleon Bellua Sam, Shengqian Xu & Faming Pan. (2019) Elevated circulating IL-17 level is associated with inflammatory arthritis and disease activity: A meta-analysis. Clinica Chimica Acta 496, pages 76-83.
Crossref
Rik Lories. 2019. Axial Spondyloarthritis. Axial Spondyloarthritis 111 120 .
Ellen M. Gravallese & Georg Schett. (2018) Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis. Nature Reviews Rheumatology 14:11, pages 631-640.
Crossref
Leonie S. Taams, Kathryn J. A. Steel, Ushani Srenathan, Lachrissa A. Burns & Bruce W. Kirkham. (2018) IL-17 in the immunopathogenesis of spondyloarthritis. Nature Reviews Rheumatology 14:8, pages 453-466.
Crossref
Abdulla Watad, Richard J. Cuthbert, Howard Amital & Dennis McGonagle. (2018) Enthesitis: Much More Than Focal Insertion Point Inflammation. Current Rheumatology Reports 20:7.
Crossref
Ismail Sari & Nigil Haroon. (2018) Disease modification in axial spondyloarthritis. Best Practice & Research Clinical Rheumatology 32:3, pages 427-439.
Crossref
Rik J. Lories. (2018) Advances in understanding the pathophysiology of spondyloarthritis. Best Practice & Research Clinical Rheumatology 32:3, pages 331-341.
Crossref
Margot Van Mechelen, Giulia Rossana Gulino, Kurt de Vlam & Rik Lories. (2017) Bone Disease in Axial Spondyloarthritis. Calcified Tissue International 102:5, pages 547-558.
Crossref
Wolfgang M. Kuebler, Sébastien Bonnet & Arata Tabuchi. (2018) Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series). Pulmonary Circulation 8:2, pages 1-13.
Crossref
Farhad Babaie, Milad Hasankhani, Hamed Mohammadi, Elham Safarzadeh, Alireza Rezaiemanesh, Reza Salimi, Behzad Baradaran & Zohreh Babaloo. (2018) The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates. Immunology Letters 196, pages 52-62.
Crossref
Rik J. Lories & Nigil Haroon. (2017) Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studies. Best Practice & Research Clinical Rheumatology 31:6, pages 877-886.
Crossref
Tao He, Yan Huang, Chen Zhang, Denghui Liu, Chao Cheng, Weidong Xu & Xiaoling Zhang. (2017) Interleukin-17A-promoted MSC2 polarization related with new bone formation of ankylosing spondylitis. Oncotarget 8:57, pages 96993-97008.
Crossref
Bin Yang, Yuanwei Xu, Xinle Liu, Zhuochun Huang & Lanlan Wang. (2017) IL-23R and IL-17A polymorphisms correlate with susceptibility of ankylosing spondylitis in a Southwest Chinese population. Oncotarget 8:41, pages 70310-70316.
Crossref
Mohn’d AbuHilal, Scott Walsh & Neil Shear. (2016) The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis. Journal of Cutaneous Medicine and Surgery 20:6, pages 509-516.
Crossref
Carlo Selmi. (2016) Autoimmunity in 2015. Clinical Reviews in Allergy & Immunology 51:1, pages 110-119.
Crossref
Ananta Paine & Christopher T. Ritchlin. (2016) Targeting the interleukin-23/17 axis in axial spondyloarthritis. Current Opinion in Rheumatology 28:4, pages 359-367.
Crossref
Chao Chen, XiaoLin Zhang, Lu Xiao, XueSong Zhang & XinLong Ma. (2016) Comparative Effectiveness of Biologic Therapy Regimens for Ankylosing Spondylitis. Medicine 95:11, pages e3060.
Crossref
Ananta Paine & Christopher Ritchlin. (2016) Bone remodeling in psoriasis and psoriatic arthritis. Current Opinion in Rheumatology 28:1, pages 66-75.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.